In this study, common adverse reactions to Peg-IFNα included fever, myalgia, fatigue, alopecia, anxiety, loss of appetite, neutropenia, elevated ALT levels, thrombocytopenia, and thyroid dysfunction (Table 3). This evidence concerns the gene IFNA2 and Thrombocytopenia.